Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

